Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris

  • Werth V
  • Joly P
  • Mimouni D
  • et al.
101Citations
Citations of this article
138Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Abstract Background Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but they have not been adequately compared in clinical trials. Methods In a randomized, controlled tria...

Cite

CITATION STYLE

APA

Werth, V. P., Joly, P., Mimouni, D., Maverakis, E., Caux, F., Lehane, P., … Chen, D. M. (2021). Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris. New England Journal of Medicine, 384(24), 2295–2305. https://doi.org/10.1056/nejmoa2028564

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free